Post written by Joseph C. Anderson, MD, MHCDS, from the Department of Veterans Affairs Medical Center, White River Junction, Vermont, and the Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA. The purpose of this study was to compare water to standard CO2 as a medium to inspect the colonic mucosa for polyp detection. …
Tag: GIE
Performance indicators in colonoscopy after certification for independent practice
Post written by Keith Siau, MBChB, MRCP, and Paul Dunckley, MBChB, FRCP, DPhil, from the Joint Advisory Group, Royal College of Physicians, London, the Department of Gastroenterology, Dudley Group Hospitals NHSFT, Dudley, and the Department of Gastroenterology, Gloucestershire Royal Hospital, Gloucester, United Kingdom. This prospective UK-wide observational study focused on the following: Quality of colonoscopy …
Continue reading Performance indicators in colonoscopy after certification for independent practice
Efficacy of autofluorescence imaging for flat neoplasm detection
Post written by Yoji Takeuchi, MD, from the Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan. Updated autofluorescence imaging (AFI) could show superior detection of flat colorectal neoplasms in the right-sided colon compared with conventional white-light imaging (WLI) in this prospective multicenter randomized controlled trial. Since flat (non-polypoid) neoplasms have a greater association …
Continue reading Efficacy of autofluorescence imaging for flat neoplasm detection
Pine-cone and villi patterns are signs suggestive of ulcerative colitis-associated colorectal cancer and dysplasia
Post written by Takahide Shinagawa, MD, from the Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan. How to survey colorectal cancer is one of the main problems in managing patients with ulcerative colitis (UC). Currently, colonoscopic surveillance is the gold standard and targeted biopsy for the suspicious lesions has become the focus of …
Increasing adenoma detection rates in the right side of the colon
Post written by Madhav Desai, MD, MPH, from the Gastroenterology and Hepatology, University of Kansas Medical Center, Kansas City, Kansas, USA. Colonoscopy prevents colon cancer and, therefore, has become a widely used screening modality. Right-sided lesions are often missed during standard colonoscopy and could account for interval colon cancer. As gastroenterologists and endoscopists, our keen …
Continue reading Increasing adenoma detection rates in the right side of the colon
Revisiting code status in patients undergoing GI endoscopy with a “do not resuscitate” order
Post written by Kyoko Wada, MD, MA, PhD, and Michael J. Szego, MHSc, PhD, from the Centre for Clinical Ethics, Providence Healthcare, St. Joseph’s Health Centre, St. Michael’s Hospital Network, and the Department of Family and Community Medicine, Dalla Lana School of Public Health, Joint Centre for Bioethics, University of Toronto, Toronto, Canada. Based on …
Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett’s esophagus
Post written by Madhav Desai, MD, MPH, from the Gastroenterology and Hepatology, University of Kansas Medical Center, Kansas City, Kansas, USA. Barrett’s esophagus (BE) is a known precursor lesion for esophageal adenocarcinoma (EAC), and we know that incidence of the latter is rising in last 30 years thereby necessitating early detection and management of this …
A trial comparing a 25-gauge EUS-FNA device with a 20-gauge EUS-FNB device
Post written by Priscilla A. van Riet, MD, from the Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. Our study focused on the optimization of EUS-guided tissue sampling. For this, we compared the diagnostic performance of a newly designed FNB needle, the 20G ProCore needle with a forward-facing bevel, to …
Continue reading A trial comparing a 25-gauge EUS-FNA device with a 20-gauge EUS-FNB device
Editor’s Choice: Role of interventional inflammatory bowel disease in the era of biologic therapy
GIE Senior Associate Editor, Dr. John R. Saltzman, MD, highlights this article from the February issue “Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group” by Bo Shen, MD, et al. There is an increasing recognition that Interventional (or therapeutic) inflammatory bowel disease …
Role of interventional inflammatory bowel disease in the era of biologic therapy
Post written by Bo Shen, MD, from the Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA. The team from the Global Interventional IBD (Gi-IBD) group and ASGE Special Interest Group in Interventional IBD put together a position statement on endoscopic management of structural and neoplastic complications of IBD. With better understanding of etiology, …
Continue reading Role of interventional inflammatory bowel disease in the era of biologic therapy
endoscopedia.com 